These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36326718)

  • 1. Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms.
    Tommerdahl KL; Kendrick J; Nelson RG; Bjornstad P
    Clin Sci (Lond); 2022 Nov; 136(21):1471-1483. PubMed ID: 36326718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of youth with type 2 diabetes and diabetic kidney disease: a comprehensive review of current treatments and future directions.
    Tommerdahl KL; Kula AJ; Bjornstad P
    Expert Opin Pharmacother; 2023 Jun; 24(8):913-924. PubMed ID: 37071054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.
    Bjornstad P; Cherney DZ; Maahs DM; Nadeau KJ
    Curr Diab Rep; 2016 Feb; 16(2):11. PubMed ID: 26803647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease.
    Bjornstad P; Cherney DZ
    Curr Diab Rep; 2018 Mar; 18(5):22. PubMed ID: 29557063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes.
    Looker HC; Pyle L; Vigers T; Severn C; Saulnier PJ; Najafian B; Mauer M; Nelson RG; Bjornstad P
    Diabetes Care; 2022 Feb; 45(2):436-443. PubMed ID: 35006272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies.
    Amatruda M; Gembillo G; Giuffrida AE; Santoro D; Conti G
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic kidney disease in children and adolescents.
    Afkarian M
    Pediatr Nephrol; 2015 Jan; 30(1):65-74; quiz 70-1. PubMed ID: 24643739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom.
    González-Pérez A; Saéz ME; Vizcaya D; Lind M; García Rodríguez LA
    Prim Care Diabetes; 2020 Aug; 14(4):381-387. PubMed ID: 31791904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.
    van Zuydam NR; Ahlqvist E; Sandholm N; Deshmukh H; Rayner NW; Abdalla M; Ladenvall C; Ziemek D; Fauman E; Robertson NR; McKeigue PM; Valo E; Forsblom C; Harjutsalo V; ; Perna A; Rurali E; Marcovecchio ML; Igo RP; Salem RM; Perico N; Lajer M; Käräjämäki A; Imamura M; Kubo M; Takahashi A; Sim X; Liu J; van Dam RM; Jiang G; Tam CHT; Luk AOY; Lee HM; Lim CKP; Szeto CC; So WY; Chan JCN; ; Ang SF; Dorajoo R; Wang L; Clara TSH; McKnight AJ; Duffy S; ; Pezzolesi MG; ; Marre M; Gyorgy B; Hadjadj S; Hiraki LT; ; Ahluwalia TS; Almgren P; Schulz CA; Orho-Melander M; Linneberg A; Christensen C; Witte DR; Grarup N; Brandslund I; Melander O; Paterson AD; Tregouet D; Maxwell AP; Lim SC; Ma RCW; Tai ES; Maeda S; Lyssenko V; Tuomi T; Krolewski AS; Rich SS; Hirschhorn JN; Florez JC; Dunger D; Pedersen O; Hansen T; Rossing P; Remuzzi G; ; Brosnan MJ; Palmer CNA; Groop PH; Colhoun HM; Groop LC; McCarthy MI
    Diabetes; 2018 Jul; 67(7):1414-1427. PubMed ID: 29703844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nidogen-1 could play a role in diabetic kidney disease development in type 2 diabetes: a genome-wide association meta-analysis.
    Khattab A; Torkamani A
    Hum Genomics; 2022 Oct; 16(1):47. PubMed ID: 36271454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease.
    Lerma E; White WB; Bakris G
    Postgrad Med; 2023 Apr; 135(3):224-233. PubMed ID: 35392754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lactate dehydrogenase and the risk of diabetic kidney disease in patients with type 2 diabetes.
    Tang L; Yang Q; Ma R; Zhou P; Peng C; Xie C; Liang Q; Wu T; Gao W; Yu H; Deng G; Dai Z; Mao N; Xiao X
    Front Endocrinol (Lausanne); 2024; 15():1369968. PubMed ID: 38567310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Genetics of Youth-Onset Type 2 Diabetes.
    Todd JN; Srinivasan S; Pollin TI
    Curr Diab Rep; 2018 Jun; 18(8):57. PubMed ID: 29931398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictive factors in diabetic kidney disease progression.
    Radcliffe NJ; Seah JM; Clarke M; MacIsaac RJ; Jerums G; Ekinci EI
    J Diabetes Investig; 2017 Jan; 8(1):6-18. PubMed ID: 27181363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
    Bakris GL; Agarwal R; Anker SD; Pitt B; Ruilope LM; Nowack C; Kolkhof P; Ferreira AC; Schloemer P; Filippatos G; ;
    Am J Nephrol; 2019; 50(5):333-344. PubMed ID: 31655812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
    Bjornstad P; Nehus E; El Ghormli L; Bacha F; Libman IM; McKay S; Willi SM; Laffel L; Arslanian S; Nadeau KJ;
    Am J Kidney Dis; 2018 Jan; 71(1):65-74. PubMed ID: 29157731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid Antagonism and Diabetic Kidney Disease.
    Lytvyn Y; Godoy LC; Scholtes RA; van Raalte DH; Cherney DZ
    Curr Diab Rep; 2019 Jan; 19(1):4. PubMed ID: 30673886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.